Hend Mohamed Abdel-Bar (Hend M Abdel-Bar)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

PloS one

Molecular pharmaceutics

University of Sadat City

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sadat City

Egypt

Lecturer :: faculty of pharmacy

National Organization for Drug Control and Research Jun 24 2007 - Dec 20 2016

Egypt

researcher :: department of pharmaceutics

Publications

Esraa M Mosalam, Aya Ibrahim Elberri, Mahmoud S Abdallah, Hend Mohamed Abdel-Bar, Abdel-Aziz A Zidan, Hany A Batakoushy, Hend E Abo Mansour
Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats. International journal of molecular sciences 25 (14) (2024)
Esraa M Mosalam, Aya Ibrahim Elberri, Mahmoud S Abdallah, Hend Mohamed Abdel-Bar, Abdel-Aziz A Zidan, Hany A Batakoushy, Hend E Abo Mansour
Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats. International journal of molecular sciences 25 (14) (2024)
Esraa M Mosalam, Aya Ibrahim Elberri, Mahmoud S Abdallah, Hend Mohamed Abdel-Bar, Abdel-Aziz A Zidan, Hany A Batakoushy, Hend E Abo Mansour
Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats. International journal of molecular sciences 25 (14) (2024)
Hadil Mohamed Aboelenin, Alaa S Tulbah, Hany W Darwish, Rania Salama, Ibrahim A Naguib, Heba A Yassin, Hend Mohamed Abdel-Bar
Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid-Polymer Hybrid Nanocarriers. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Hadil Mohamed Aboelenin, Alaa S Tulbah, Hany W Darwish, Rania Salama, Ibrahim A Naguib, Heba A Yassin, Hend Mohamed Abdel-Bar
Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid-Polymer Hybrid Nanocarriers. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Hend Mohamed Abdel-Bar, Alaa S Tulbah, Hany W Darwish, Rania Salama, Ibrahim A Naguib, Heba A Yassin, Hadil Mohamed Aboelenin
Quetiapine Albumin Nanoparticles as an Efficacious Platform for Brain Deposition and Potentially Improved Antipsychotic Activity. Pharmaceutics 15 (7) (2023)
Hadil Mohamed Aboelenin, Marwa F Ahmed, Ibrahim A Naguib, Shaymaa W El-Far, Mohammed M Ghoneim, Izzeddin Alsalahat, Hend Mohamed Abdel-Bar
Utilization of Polymeric Micelles as a Lucrative Platform for Efficient Brain Deposition of Olanzapine as an Antischizophrenic Drug via Intranasal Delivery. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Shaymaa A Abd-Algaleel, Hend Mohamed Abdel-Bar, Abdelkader A Metwally, Rania M Hathout
Evolution of the Computational Pharmaceutics Approaches in the Modeling and Prediction of Drug Payload in Lipid and Polymeric Nanocarriers. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Shaymaa A Abd-Algaleel, Abdelkader A Metwally, Hend Mohamed Abdel-Bar, Dina H Kassem, Rania M Hathout
Synchronizing In Silico, In Vitro, and In Vivo Studies for the Successful Nose to Brain Delivery of an Anticancer Molecule. Molecular pharmaceutics 18 (10) (2021)
Mohamed Hamdi, Hend Mohamed Abdel-Bar, Enas Elmowafy, Khuloud T Al-Jamal, Gehanne A S Awad
An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect. PloS one 15 (1) (2020)

Hend Mohamed Abdel-Bar.css-eqlu8i{font-size:small;padding-left:4px;} (Hend M Abdel-Bar)

Publication Activity (10 Years)

Top Topics

Top Venues

Hend Mohamed Abdel-Bar (Hend M Abdel-Bar)